世界の悪性黒子型黒色腫治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Lentigo Maligna Melanoma Therapeutic Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5830 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、悪性黒子型黒色腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、免疫療法、標的療法、放射線療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・悪性黒子型黒色腫治療の市場動向 ・企業の競争状況、市場シェア ・悪性黒子型黒色腫治療の種類別市場規模と予測2016-2027（化学療法、免疫療法、標的療法、放射線療法） ・悪性黒子型黒色腫治療の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・悪性黒子型黒色腫治療の北米市場規模2016-2027（アメリカ、カナダ） ・悪性黒子型黒色腫治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・悪性黒子型黒色腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・悪性黒子型黒色腫治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・悪性黒子型黒色腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Chiron Corporation、Amgen、Bristol-Myers Squibb、Merck & Co、Novartis、Roche） ・結論

Lentigo maligna is a subtype of melanoma in situ that is characterized by an atypical proliferation of melanocytes within the basal epidermis; lentigo maligna that invades the dermis is termed lentigo maligna melanoma.

Market Analysis and Insights: Global Lentigo Maligna Melanoma Therapeutic Market
The global Lentigo Maligna Melanoma Therapeutic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lentigo Maligna Melanoma Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lentigo Maligna Melanoma Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lentigo Maligna Melanoma Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lentigo Maligna Melanoma Therapeutic market.

Global Lentigo Maligna Melanoma Therapeutic Scope and Market Size
Lentigo Maligna Melanoma Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lentigo Maligna Melanoma Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Immunotherapy
Targeted Therapy
Radiation Therapy

Segment by Application
Hospital
Clinic
Other

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Chiron Corporation
Amgen
Bristol-Myers Squibb
Merck & Co
Novartis
Roche

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lentigo Maligna Melanoma Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Immunotherapy
1.2.4 Targeted Therapy
1.2.5 Radiation Therapy
1.3 Market by Application
1.3.1 Global Lentigo Maligna Melanoma Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Lentigo Maligna Melanoma Therapeutic Market Perspective (2016-2027)
2.2 Lentigo Maligna Melanoma Therapeutic Growth Trends by Regions
2.2.1 Lentigo Maligna Melanoma Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lentigo Maligna Melanoma Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Lentigo Maligna Melanoma Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Lentigo Maligna Melanoma Therapeutic Industry Dynamic
2.3.1 Lentigo Maligna Melanoma Therapeutic Market Trends
2.3.2 Lentigo Maligna Melanoma Therapeutic Market Drivers
2.3.3 Lentigo Maligna Melanoma Therapeutic Market Challenges
2.3.4 Lentigo Maligna Melanoma Therapeutic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Lentigo Maligna Melanoma Therapeutic Players by Revenue
3.1.1 Global Top Lentigo Maligna Melanoma Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Lentigo Maligna Melanoma Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Lentigo Maligna Melanoma Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lentigo Maligna Melanoma Therapeutic Revenue
3.4 Global Lentigo Maligna Melanoma Therapeutic Market Concentration Ratio
3.4.1 Global Lentigo Maligna Melanoma Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lentigo Maligna Melanoma Therapeutic Revenue in 2020
3.5 Lentigo Maligna Melanoma Therapeutic Key Players Head office and Area Served
3.6 Key Players Lentigo Maligna Melanoma Therapeutic Product Solution and Service
3.7 Date of Enter into Lentigo Maligna Melanoma Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Lentigo Maligna Melanoma Therapeutic Breakdown Data by Type
4.1 Global Lentigo Maligna Melanoma Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Lentigo Maligna Melanoma Therapeutic Forecasted Market Size by Type (2022-2027)

5 Lentigo Maligna Melanoma Therapeutic Breakdown Data by Application
5.1 Global Lentigo Maligna Melanoma Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Lentigo Maligna Melanoma Therapeutic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Lentigo Maligna Melanoma Therapeutic Market Size (2016-2027)
6.2 North America Lentigo Maligna Melanoma Therapeutic Market Size by Type
6.2.1 North America Lentigo Maligna Melanoma Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Lentigo Maligna Melanoma Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Lentigo Maligna Melanoma Therapeutic Market Size by Type (2016-2027)
6.3 North America Lentigo Maligna Melanoma Therapeutic Market Size by Application
6.3.1 North America Lentigo Maligna Melanoma Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Lentigo Maligna Melanoma Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Lentigo Maligna Melanoma Therapeutic Market Size by Application (2016-2027)
6.4 North America Lentigo Maligna Melanoma Therapeutic Market Size by Country
6.4.1 North America Lentigo Maligna Melanoma Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Lentigo Maligna Melanoma Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Lentigo Maligna Melanoma Therapeutic Market Size (2016-2027)
7.2 Europe Lentigo Maligna Melanoma Therapeutic Market Size by Type
7.2.1 Europe Lentigo Maligna Melanoma Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Lentigo Maligna Melanoma Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Lentigo Maligna Melanoma Therapeutic Market Size by Type (2016-2027)
7.3 Europe Lentigo Maligna Melanoma Therapeutic Market Size by Application
7.3.1 Europe Lentigo Maligna Melanoma Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Lentigo Maligna Melanoma Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Lentigo Maligna Melanoma Therapeutic Market Size by Application (2016-2027)
7.4 Europe Lentigo Maligna Melanoma Therapeutic Market Size by Country
7.4.1 Europe Lentigo Maligna Melanoma Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Lentigo Maligna Melanoma Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Size by Type
8.2.1 Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Size by Application
8.3.1 Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Size by Region
8.4.1 Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Lentigo Maligna Melanoma Therapeutic Market Size (2016-2027)
9.2 Latin America Lentigo Maligna Melanoma Therapeutic Market Size by Type
9.2.1 Latin America Lentigo Maligna Melanoma Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Lentigo Maligna Melanoma Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Lentigo Maligna Melanoma Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Lentigo Maligna Melanoma Therapeutic Market Size by Application
9.3.1 Latin America Lentigo Maligna Melanoma Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Lentigo Maligna Melanoma Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Lentigo Maligna Melanoma Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Lentigo Maligna Melanoma Therapeutic Market Size by Country
9.4.1 Latin America Lentigo Maligna Melanoma Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Lentigo Maligna Melanoma Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Size by Type
10.2.1 Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Size by Application
10.3.1 Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Size by Country
10.4.1 Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Chiron Corporation
11.1.1 Chiron Corporation Company Details
11.1.2 Chiron Corporation Business Overview
11.1.3 Chiron Corporation Lentigo Maligna Melanoma Therapeutic Introduction
11.1.4 Chiron Corporation Revenue in Lentigo Maligna Melanoma Therapeutic Business (2016-2021)
11.1.5 Chiron Corporation Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Lentigo Maligna Melanoma Therapeutic Introduction
11.2.4 Amgen Revenue in Lentigo Maligna Melanoma Therapeutic Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Lentigo Maligna Melanoma Therapeutic Introduction
11.3.4 Bristol-Myers Squibb Revenue in Lentigo Maligna Melanoma Therapeutic Business (2016-2021)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Merck & Co
11.4.1 Merck & Co Company Details
11.4.2 Merck & Co Business Overview
11.4.3 Merck & Co Lentigo Maligna Melanoma Therapeutic Introduction
11.4.4 Merck & Co Revenue in Lentigo Maligna Melanoma Therapeutic Business (2016-2021)
11.4.5 Merck & Co Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Lentigo Maligna Melanoma Therapeutic Introduction
11.5.4 Novartis Revenue in Lentigo Maligna Melanoma Therapeutic Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Lentigo Maligna Melanoma Therapeutic Introduction
11.6.4 Roche Revenue in Lentigo Maligna Melanoma Therapeutic Business (2016-2021)
11.6.5 Roche Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Lentigo Maligna Melanoma Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Immunotherapy
Table 4. Key Players of Targeted Therapy
Table 5. Key Players of Radiation Therapy
Table 6. Global Lentigo Maligna Melanoma Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Lentigo Maligna Melanoma Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Lentigo Maligna Melanoma Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Lentigo Maligna Melanoma Therapeutic Market Share by Regions (2016-2021)
Table 10. Global Lentigo Maligna Melanoma Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Lentigo Maligna Melanoma Therapeutic Market Share by Regions (2022-2027)
Table 12. Lentigo Maligna Melanoma Therapeutic Market Trends
Table 13. Lentigo Maligna Melanoma Therapeutic Market Drivers
Table 14. Lentigo Maligna Melanoma Therapeutic Market Challenges
Table 15. Lentigo Maligna Melanoma Therapeutic Market Restraints
Table 16. Global Lentigo Maligna Melanoma Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Lentigo Maligna Melanoma Therapeutic Market Share by Players (2016-2021)
Table 18. Global Top Lentigo Maligna Melanoma Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lentigo Maligna Melanoma Therapeutic as of 2020)
Table 19. Ranking of Global Top Lentigo Maligna Melanoma Therapeutic Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Lentigo Maligna Melanoma Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Lentigo Maligna Melanoma Therapeutic Product Solution and Service
Table 23. Date of Enter into Lentigo Maligna Melanoma Therapeutic Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Lentigo Maligna Melanoma Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Lentigo Maligna Melanoma Therapeutic Revenue Market Share by Type (2016-2021)
Table 27. Global Lentigo Maligna Melanoma Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Lentigo Maligna Melanoma Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Lentigo Maligna Melanoma Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Lentigo Maligna Melanoma Therapeutic Revenue Market Share by Application (2016-2021)
Table 31. Global Lentigo Maligna Melanoma Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Lentigo Maligna Melanoma Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Lentigo Maligna Melanoma Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Lentigo Maligna Melanoma Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Lentigo Maligna Melanoma Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Lentigo Maligna Melanoma Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Lentigo Maligna Melanoma Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Lentigo Maligna Melanoma Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Lentigo Maligna Melanoma Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Lentigo Maligna Melanoma Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Lentigo Maligna Melanoma Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Lentigo Maligna Melanoma Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Lentigo Maligna Melanoma Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Lentigo Maligna Melanoma Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Lentigo Maligna Melanoma Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Lentigo Maligna Melanoma Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Lentigo Maligna Melanoma Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Lentigo Maligna Melanoma Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Lentigo Maligna Melanoma Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Lentigo Maligna Melanoma Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 63. Chiron Corporation Company Details
Table 64. Chiron Corporation Business Overview
Table 65. Chiron Corporation Lentigo Maligna Melanoma Therapeutic Product
Table 66. Chiron Corporation Revenue in Lentigo Maligna Melanoma Therapeutic Business (2016-2021) & (US$ Million)
Table 67. Chiron Corporation Recent Development
Table 68. Amgen Company Details
Table 69. Amgen Business Overview
Table 70. Amgen Lentigo Maligna Melanoma Therapeutic Product
Table 71. Amgen Revenue in Lentigo Maligna Melanoma Therapeutic Business (2016-2021) & (US$ Million)
Table 72. Amgen Recent Development
Table 73. Bristol-Myers Squibb Company Details
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Lentigo Maligna Melanoma Therapeutic Product
Table 76. Bristol-Myers Squibb Revenue in Lentigo Maligna Melanoma Therapeutic Business (2016-2021) & (US$ Million)
Table 77. Bristol-Myers Squibb Recent Development
Table 78. Merck & Co Company Details
Table 79. Merck & Co Business Overview
Table 80. Merck & Co Lentigo Maligna Melanoma Therapeutic Product
Table 81. Merck & Co Revenue in Lentigo Maligna Melanoma Therapeutic Business (2016-2021) & (US$ Million)
Table 82. Merck & Co Recent Development
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Lentigo Maligna Melanoma Therapeutic Product
Table 86. Novartis Revenue in Lentigo Maligna Melanoma Therapeutic Business (2016-2021) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. Roche Company Details
Table 89. Roche Business Overview
Table 90. Roche Lentigo Maligna Melanoma Therapeutic Product
Table 91. Roche Revenue in Lentigo Maligna Melanoma Therapeutic Business (2016-2021) & (US$ Million)
Table 92. Roche Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lentigo Maligna Melanoma Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Immunotherapy Features
Figure 4. Targeted Therapy Features
Figure 5. Radiation Therapy Features
Figure 6. Global Lentigo Maligna Melanoma Therapeutic Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Lentigo Maligna Melanoma Therapeutic Report Years Considered
Figure 11. Global Lentigo Maligna Melanoma Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Lentigo Maligna Melanoma Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Lentigo Maligna Melanoma Therapeutic Market Share by Regions: 2020 VS 2027
Figure 14. Global Lentigo Maligna Melanoma Therapeutic Market Share by Regions (2022-2027)
Figure 15. Global Lentigo Maligna Melanoma Therapeutic Market Share by Players in 2020
Figure 16. Global Top Lentigo Maligna Melanoma Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lentigo Maligna Melanoma Therapeutic as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Lentigo Maligna Melanoma Therapeutic Revenue in 2020
Figure 18. Global Lentigo Maligna Melanoma Therapeutic Revenue Market Share by Type (2016-2021)
Figure 19. Global Lentigo Maligna Melanoma Therapeutic Revenue Market Share by Type (2022-2027)
Figure 20. North America Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Lentigo Maligna Melanoma Therapeutic Market Share by Type (2016-2027)
Figure 22. North America Lentigo Maligna Melanoma Therapeutic Market Share by Application (2016-2027)
Figure 23. North America Lentigo Maligna Melanoma Therapeutic Market Share by Country (2016-2027)
Figure 24. United States Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Lentigo Maligna Melanoma Therapeutic Market Share by Type (2016-2027)
Figure 28. Europe Lentigo Maligna Melanoma Therapeutic Market Share by Application (2016-2027)
Figure 29. Europe Lentigo Maligna Melanoma Therapeutic Market Share by Country (2016-2027)
Figure 30. Germany Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Share by Region (2016-2027)
Figure 40. China Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Lentigo Maligna Melanoma Therapeutic Market Share by Type (2016-2027)
Figure 48. Latin America Lentigo Maligna Melanoma Therapeutic Market Share by Application (2016-2027)
Figure 49. Latin America Lentigo Maligna Melanoma Therapeutic Market Share by Country (2016-2027)
Figure 50. Mexico Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Share by Country (2016-2027)
Figure 56. Turkey Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Chiron Corporation Revenue Growth Rate in Lentigo Maligna Melanoma Therapeutic Business (2016-2021)
Figure 60. Amgen Revenue Growth Rate in Lentigo Maligna Melanoma Therapeutic Business (2016-2021)
Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Lentigo Maligna Melanoma Therapeutic Business (2016-2021)
Figure 62. Merck & Co Revenue Growth Rate in Lentigo Maligna Melanoma Therapeutic Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Lentigo Maligna Melanoma Therapeutic Business (2016-2021)
Figure 64. Roche Revenue Growth Rate in Lentigo Maligna Melanoma Therapeutic Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---